Price $4.64 |
Market Cap
159.7M
|
Sector Health Care |
Div. Growth
-
|
P/E
-
|
P/B
2.29
|
P/S
9.49
|
Dividend %
-
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-23.8K
|
FCF
-0.7
|
Op. Margin
-213.90%
|
Net Margin
-196.40%
|
ROE
-40.70%
|
ROI
-40.40%
|
ROA
-29.10%
|
EPS Growth
-7.50%
|
Current Ratio
7.9
|
Debt/Equity
14.90%
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
Harvard Bioscience, Inc. (HBIO) | $4.09 | - | - | 183.6M | Strong Buy |
Chromadex Corp (CDXC) | $3.97 | - | - | 105.8M | Strong Buy |
Cidara Therapeutics Inc (CDTX) | $0.72 | - | - | 78M | Strong Buy |
Sonoma Pharmaceuticals Inc (SNOA) | $0.17 | - | - | 2.3M | Strong Buy |
Spruce Biosciences Inc (SPRB) | $0.71 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More